No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort

AIDS

Volumn 20, Issue 7, 2006, Pages 1076-1079

  Descamps, Diane ^a   Damond, Florence ^a   Bénard, Antoine ^b   Matheron, Sophie ^a   Campa, Pauline ^c   Taieb, Audrey ^b   Yahyaoui, Réda ^a   Chêne, Geneviève ^b   Brun Vézinet, Françoise ^a  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; EXPOSURE; FEMALE; FRANCE; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS LOAD;

ADULT; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FLAVIVIRIDAE INFECTIONS; FRANCE; GB VIRUS C; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; PREVALENCE; RNA, VIRAL; VIRAL LOAD;

EID: 33646375459     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000222086.29164.6e     Document Type: Article

References (18)

1. Heringlake S, Ockenga J, Tillmann HL, Trautwein C, Meissner D, Stoll M, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998; 177:1723-1726.
2. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquit Immune Defic Syndr Hum Retrovirol 1998; 17:209-213.
3. Letrere JJ, Roudot-Thoraval F, Morand-Joubert L, Petit JC, Lerable J, Thauvin M, Mariotti M. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179:783-789.
4. Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 2000; 132:959-963.
5. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilbur JC, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345:715-724.
6. Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001; 345:707-714.
7. Williams CA, Zori RT, Stone JW, Gray BA, Cantu ES, Ostrer H. Maternal origin of 15q11-13 deletions in Angelman syndrome suggests a role for genomic imprinting. Am J Med Genet 1990; 35:350-353.
8. Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, et al. GB virus C coinfection and HIV-1 disease progression: the Amsterdam Cohort Study. J Infect Dis 2005; 191:678-685.
9. Sabin CA, Devereux H, Kinson Z, Griffioen A, Brown D, Dusheiko G, Lee CA. Effect of coinfection with hepatitis G virus on HIV disease progression in hemophilic men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:546-548.
10. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 2002; 16:2482-2485.
11. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18:877-886.
12. Brumme ZL, Chan KJ, Dong WWY, Mo T, Wynhoven B, Hogg RS, et al. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy. AIDS 2002; 16:1929-1933.
13. Kaye S, Howard M, Alabi A, Hansmann A, Whittle H, Schim van der Loeff M. No observed effect of GB virus C coinfection on disease progression in a cohort of African woman infected with HIV-1 or HIV-2. Clin Infect Dis 2005; 40:876-878.
14. Xiang J, Klinzman D, McLinden J, Schmidt WN, LaBrecque DR, Gish R, Stapleton JT. Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol 1998; 72:2738-2744.
15. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Bess G, Engel AM. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349:318-320.
16. Casteling A, Song E, Sim J, Blaauw D, Heyns A, Schweizer R, et al. GB virus C prevalence in blood donors and high risk groups for parenterally transmitted agents from Gauteng, South Africa. J Med Virol 1998; 55:103-108.
17. Sathar MA, Soni PN, Naicker S, Conradie J, Lockhat F, Gouws E. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa. J Med Virol 1999; 59:38-44.
18. Dille BJ, Surowy TK, Gutierrez RA, Coleman PF, Knigge MF, Carrick RJ, et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1997; 175:458-461.